We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$736M
AUM Growth
-$154M
Cap. Flow
-$53.9M
Cap. Flow %
-7.32%
Top 10 Hldgs %
22.86%
Holding
152
New
40
Increased
35
Reduced
25
Closed
52

Top Buys

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$15.2M
2
HURN icon
Huron Consulting
HURN
+$14.2M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.7M
4
AIT icon
Applied Industrial Technologies
AIT
+$13.1M
5
OLLI icon
Ollie's Bargain Outlet
OLLI
+$11.6M

Top Sells

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$18.3M
2
FRPT icon
Freshpet
FRPT
+$13.4M
3
RRR icon
Red Rock Resorts
RRR
+$12.9M
4
COHR icon
Coherent
COHR
+$12.7M
5
FORM icon
FormFactor
FORM
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32.88%
2 Technology 23.88%
3 Industrials 20.04%
4 Consumer Staples 6.39%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS
1
DELISTED
Chart Industries
GTLS
$19.9M 2.7%
118,893
+37,744
+47% +$6.45M
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.7M 2.54%
327,894
+49,499
+18% +$2.81M
SITM icon
3
SiTime
SITM
$16B
$17.1M 2.33%
105,039
+10,698
+11% +$2.02M
KNSL icon
4
Kinsale Capital Group
KNSL
$8.12B
$17.1M 2.32%
74,268
+42,103
+131% +$9.31M
ACHC icon
5
Acadia Healthcare
ACHC
$2.76B
$16.4M 2.23%
242,948
-10,832
-4% -$756K
HURN icon
6
Huron Consulting
HURN
$2.41B
$16.3M 2.22%
+251,305
New +$14.2M
SWAV
7
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$16.2M 2.2%
84,862
-9,355
-10% -$1.65M
GTLB icon
8
GitLab
GTLB
$5.83B
$16.2M 2.2%
304,165
+220,275
+263% +$10.2M
HALO icon
9
Halozyme
HALO
$9.79B
$15.4M 2.1%
+350,935
New +$15.2M
SPT icon
10
Sprout Social
SPT
$516M
$14.9M 2.02%
256,750
+57,949
+29% +$3.37M
HRMY icon
11
Harmony Biosciences
HRMY
$2.04B
$14.8M 2.01%
+303,865
New +$13.7M
BOOT icon
12
Boot Barn
BOOT
$4.51B
$14.2M 1.93%
206,321
+95,606
+86% +$8.19M
LFUS icon
13
Littelfuse
LFUS
$11.2B
$13.6M 1.85%
53,486
+22,955
+75% +$5.76M
OLLI icon
14
Ollie's Bargain Outlet
OLLI
$4.44B
$13.4M 1.83%
+228,850
New +$11.6M
CYTK icon
15
Cytokinetics
CYTK
$10.5B
$13.1M 1.78%
333,272
+68,574
+26% +$2.76M
AIT icon
16
Applied Industrial Technologies
AIT
$12.8B
$12.5M 1.7%
+129,825
New +$13.1M
PLAY icon
17
Dave & Buster's
PLAY
$377M
$12.2M 1.66%
371,884
-28,849
-7% -$1.16M
STAA icon
18
STAAR Surgical
STAA
$1.21B
$12.1M 1.64%
170,005
+95,675
+129% +$6.16M
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.59B
$12.1M 1.64%
416,650
+190,434
+84% +$5.45M
INSP icon
20
Inspire Medical Systems
INSP
$1.45B
$11.9M 1.61%
65,004
-38,694
-37% -$7.72M
HQY icon
21
HealthEquity
HQY
$8.41B
$11.2M 1.52%
182,888
+139,108
+318% +$8.91M
SOVO
22
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$11.1M 1.5%
697,635
+300,129
+76% +$4.36M
CWST icon
23
Casella Waste Systems
CWST
$5.71B
$10.6M 1.44%
145,492
+88,082
+153% +$6.71M
OPCH icon
24
Option Care Health
OPCH
$3.45B
$10.5M 1.43%
+378,875
New +$10.8M
RBC icon
25
RBC Bearings
RBC
$17.4B
$10.4M 1.42%
56,400
+7,000
+14% +$1.24M
1
2 3 4 5

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return

Lisanti Capital Growth's Q2 2022 Portfolio in Review

As of Q2 2022, Lisanti Capital Growth held 152 positions worth $736M, down 17% from $890M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth withdrew a net $53.9M in Q2 2022, closing 52 positions and reducing 25 holdings. Its most notable exit was MaxLinear, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Halozyme worth $15.4M.

  • Lisanti Capital Growth's largest Q2 2022 buy was Halozyme: 350,935 shares worth $15.4M.
  • Lisanti Capital Growth added most to GitLab in Q2 2022, an estimated $10.2M increase.
  • Lisanti Capital Growth's biggest Q2 2022 reduction was Pacira BioSciences, cutting an estimated $11.2M.
  • Lisanti Capital Growth fully exited MaxLinear in Q2 2022, selling an estimated $18.3M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $736M portfolio in Q2 2022.
  • Lisanti Capital Growth opened 40 new positions and closed 52 in Q2 2022.
  • Lisanti Capital Growth's portfolio value fell 17% quarter-over-quarter to $736M.

Based on Lisanti Capital Growth's 13F filing for Q2 2022, filed 3 Aug 2022.